Knowing that you depend on our research and insight to provide hope in alleviating the suffering and dysfunction caused by mental and other disorders through clinical trials, we’ve created this multimedia section to find and share resources. Hear from CEO and Founder, Dr. Andrew J. Cutler as he discusses key issues in a variety of mediums such as podcasts or published articles in PDF format. As part of our commitment to keeping our information easily accessible, we have created this area so you can keep up to date on the latest research and treatment innovations as well as learn more about the credentials of our esteemed doctors.

Videos

Dr. Andrew J. Cutler discusses the importance and advantages of clinical trials on Bay News Channel 9. WATCH VIDEO.

New clinical study for Major Depressive Disorder. WATCH VIDEO.

Podcasts

The Reality of ADHD in Adults: Diagnostic Issues

The podcast series titled “The Reality of ADHD in Adults” is divided into three stand-alone parts. Part 1, Diagnostic Issues, discusses the evolution of ADHD from childhood to adulthood, and provides information on how the disorder can be identified in different age groups, using adequate rating scales.

The Reality of ADHD in Adults: Treatment Issues

The podcast series titled “The Reality of ADHD in Adults” is divided into three stand-alone parts. Part 2, Treatment Issues, discusses the different medications used to treat ADHD and elaborates on the differences and similarities between treating children and adults with the disorder. Different drug formulations are also mentioned in this podcast.

The Reality of ADHD in Adults: Comorbidities in ADHD

The podcast series titled “The Reality of ADHD in Adults” is divided into three stand-alone parts. Part 3, Comorbidities in ADHD, elaborates on the different comorbidities present in children and adults with ADHD, and discusses how to best treat them.

Research Data Posters

Extended release quetiapine fumarate (quetiapine XR) monotherapy for generalized anxiety disorder (GAD): a randomised, placebo- and escitalopram-controlled study. 2009. VIEW POSTER.

Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar mania. Version 1.  2008. VIEW POSTER.

Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar mania. Version 2.  2008. VIEW POSTER.

Efficacy and tolerability of extended release quetipine fumarate (quetiapine XR) monotherapy in the treatment of generalized anxiety disorder (GAD). 2008. VIEW POSTER.

The Metabolic Profile Of Iloperidone: Summary Of Phase 3 Schizophrenia Trials. 2008. VIEW POSTER.

Extended release quetiapine fumarate (quetiapine XR) monotherapy in the treatment of patients with major depressive disorder (MDD). 2008. VIEW POSTER.

Extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with major depressive disorder (MDD): results from a double-blind, randomized Phase III study. 2007. VIEW POSTER.

Long-Term Efficacy, Safety, and Tolerability of Mixed Amphetamine Salts Extended Release in the Treatment of Adolescents With ADHD. 2007. VIEW POSTER.

Predictors Of Response To Treatment Of Bipolar Disorder With Extended-Release Carbamazepine Capsules In 2 Double-Blind, Randomized, Placebo-Controlled Trials. 2005. VIEW POSTER.

Efficacy Of Switching To Carbamazepine Extended-Release Capsules In Bipolar Disorder. 2005. VIEW POSTER.

Publications / Research

Iloperidone: a new option for the treatment of schizophrenia

Drug profile article by Dr. Andrew J. Cutler. www.expert-reviews.com. Expert Rev. Neurother. 9(12), 1727–1741 (2009).

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. J Clin Psychiatry 70:4, April 2009. Copyright 2009 Physicians Postgraduate Press, Inc. By Andrew J. Cutler, M.D.; Stuart A. Montgomery, M.D.; David Feifel, M.D., Ph.D.; Arthur Lazarus, M.D., M.B.A.; Mikael Åström, M.Sc., Ph.L.; and Martin Brecher, M.D., D.M.Sc., M.B.A.

Four-Week Double-Blind Placebo and Ziprasidone Controlled Trial of lloperidone in Patients With Acute Exacerbations of Schizophrenia

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. Journal of Clinical Psychopharmacology, April 2008. Volume 28 - Number 2, Supplement 1. By Andrew J. Cutler, MD, Amir J. Kalali, MD, Peter J. Weiden, MD, Jennifer Hamilton, MS, and Curt D. Wolfgang, PhD.

A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. American Journal of Psychiatry, 2005. 162: 1351-1360. By Joseph R. Calabrese, MD, Paul E. Keck, Jr., MD, Wayne Macfadden, MD, Margaret Minkwitz, PhD. Terence A. Ketter, MD, Richard H. Weisler, MD, Andrew J. Cutler, MD, Robin McCoy, RN, Ellis Wilson, MS, Jamie Mullen, MD, The BOLDER Study Group.

Dosing Atypical Antipsychotics

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. CNS Spectrums: The International Journal Of Neuropsychiatric Medicine. Volume 13 - Number 5 (Suppl 9). By Andrew Cutler, MD, Sara Ball, MS, and Stephen M. Stahl, MD, PhD.

Extended-Release Carbamamazepine Capsules as Monotheraphy for Acute Mania in Bipolar Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. J Clin Psychiatry 66:3, March 2005. Copyright 2005 Physicians Postgraduate Press, Inc. By Richard H. Weisler, MD, Paul E. Keck, Jr., MD, Alan C. Swann, MD, Andrew J. Cutler, MD, Terence A. Ketter, MD and Amir H. Kalali, MD, for the SPD417 Study Group.

The Efficacy and Safety of Lower Doses of Aripiprazole for the Treatment of Patients with Acute Exacerbation of Schizophrenia

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. CNS Spectrums Volume 11 number - 9, 2006. By Andrew J. Cutler, MD, Ronald N. Marcus, MD,  Sterling A. Hardy, MS, Amy O'Donnell, MD, William H. Carson, MD and Robert D. McQuade, PhD.

The Use of Antiepileptic Drugs in Bipoloar Disorders: A Review Based on Evidence From Controlled Trials

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. CNS Spectrums Volume 11 number - 10, October 2006. By Richard H. Weisler, MD, Andrew J. Cutler, MD, James C. Ballenger, MD, Robert M. Post, MD and Terence A. Ketter, MD.

An Interim Analysis of the Quality of Life, Effectiveness, Safety and Tolerability (QU.E.S.T.) Evaluation of Mixed Amphetamine Salts Extended Release in Adults With ADHD

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. CNS Spectrums - December 2005. Volume 10 - Number 12 (suppl 20). By David W. Goodman, MD, Lawrence Ginsber, MD, Richard H. Weisler, MD, Andrew J. Cutler, MD, and Paul Hodgkins, PhD, PMP, RAC.

Aripiprazole monotherapy in the treatment of acute bipolar I mania: A randomized, double-blind, placebo- and lithium-controlled study

Research article by Dr. Andrew J. Cutler, founder of Florida Clinical Research Center. Journal of Affective Disorders 112 - 2009. By P.E. Keck a,⁎, P.J. Orsulak b,c, A.J. Cutler d, R. Sancheze, A. Torbeyns f, R.N. Marcusg, R.D. McQuadee, W.H. Carsone The CN138-135 Study Group 1.